T. Tatlisumak et al., EFFECT OF BASIC FIBROBLAST GROWTH-FACTOR ON EXPERIMENTAL FOCAL ISCHEMIA STUDIED BY DIFFUSION-WEIGHTED AND PERFUSION IMAGING, Stroke, 27(12), 1996, pp. 2292-2297
Background and Purpose Basic fibroblast growth factor (bFGF) has docum
ented neuroprotective properties. This study was performed to evaluate
the effects of bFGF on infarct size when administered 30 minutes afte
r induction of focal cerebral ischemia in rats. Diffusion-weighted and
perfusion MRI were used during the drug infusion. Methods We blindly
randomized 20 Sprague-Dawley rats to receive either drug (n=10) or veh
icle (n=10). The animals underwent middle cerebral artery (MCA) occlus
ion using the suture model. Diffusion-weighted MRI was initiated 30 mi
nutes after induction of ischemia and repeated frequently for 3.5 hour
s. Drug (45 mu g/kg per hour) or vehicle (saline) infusion began 30 mi
nutes after MCA occlusion and continued for 3 hours. Perfusion images
were made at 25, 90, and 150 minutes after MCA occlusion. The animals
were killed after 24 hours of permanent MCA occlusion, and brains were
stained with 2,3,5-triphenyltetrazolium chloride (TTC). Results The T
TC-derived, corrected infarct volume postmortem in the bFGF-treated gr
oup was significantly smaller than that in controls (126.6+/-51.9 vers
us 180.2+/-54.9 mm(3), mean+/-SD, P=.038). Diffusion imaging showed es
sentially equal lesion volumes 3 hours after MCA occlusion (195.4+/-61
mm(3) in the drug-treated group and 194.4+/-65 mm(3) in controls). At
4 hours, ischemic lesion size was 182.1+/-56.9 mm(3) in treated anima
ls and 222.9+/-88.7 mm(3) in the controls (P=.24, NS). Perfusion imagi
ng did not show a change of cerebral perfusion within ischemic brain r
egions in the bFGF group during the infusion. No behavioral or physiol
ogical side effects were observed. Conclusions bFGF is a safe and effe
ctive treatment for focal cerebral ischemia in rats. We observed a mod
est delayed difference of ischemic lesion size in vivo with diffusion
MRI. The diffusion-weighted MRI findings suggest a potential delayed t
herapeutic effect of bFGF, and the perfusion imaging findings imply th
at the effect is not due to increased blood flow to the ischemic regio
n.